Biotech · Private company
ESSA Pharmaceuticals
Track this companyFree. Adds ESSA Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- EnzalutamidePhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EPI-7386 with EnzalutamidePhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Abiraterone acetatePhase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- ApalutamidePhase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EPI-7386 (BID)Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EPI-7386 (QD)Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPCPHASE1_PHASE2 · TERMINATED · started Dec 21, 2021ClinicalTrials.gov NCT05075577 · fetched Nov 12, 2026
- Oral EPI-7386 in Patients with Castration-Resistant Prostate CancerPHASE1 · TERMINATED · started Jun 23, 2020ClinicalTrials.gov NCT04421222 · fetched Nov 12, 2026